North America Archives - Page 21 of 39 - Journal for Clinical Studies

Current Edition

Europe

Sutimlimab shows promise for hard-to-treat, rare blood disorder

In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare c...

20 December 2018 Europe | news | North America | Regional News

Continue Reading →

news

XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study

Biomarkers Predict Significantly Higher Rates of Treatment Response to Bermekimab in Advanced Cancer Patients AUSTIN, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- XBiotec...

20 December 2018 news | North America | Regional News

Continue Reading →

news

PCI Continues to Invest According to Market Demand as Specialist 2-8°C Cold Chain Capabilities Become Operational at Hay-on-Wye, UK Site

Hay-on-Wye Center of Excellence increases capacity for onsite 2-8°C Cold Chain storage. Philadelphia, USA – December 10, 2018 PCI Pharma Services (PCI), full-service...

10 December 2018 news | North America | Regional News

Continue Reading →

Australasia

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commer...

7 December 2018 Australasia | news | North America | Regional News

Continue Reading →

news

CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma

In their phase-2 study of tisagenlecleucel (marketed as KYMRIAH®), to be published on-line Dec. 1, 2018 in the New England Journal of Medicine, an international team ...

6 December 2018 news | North America | Regional News

Continue Reading →

news

Cannabis-based compound may reduce seizures in children with epilepsy

Interest has been growing in the use of cannabinoids - the active chemicals in cannabis or marijuana - for the treatment of epilepsy in children. A recent Epilepsia a...

6 December 2018 news | North America

Continue Reading →

news

Polyphor announces positive results from the FDA Type B Guidance meeting on the planned Phase III study for balixafortide

The proposed study is intended to support the global registration of balixafortide. Polyphor expects to enroll the first patient in the second quarter of 2019. Polyph...

6 December 2018 news | North America | Regional News

Continue Reading →

Europe

Botulinum toxin injections show promise to suppress postoperative atrial fibrillation

Postoperative atrial fibrillation (POAF) is a common complication, affecting one quarter to one half of all patients following cardiac surgery. It can result in heart...

29 November 2018 Europe | news | North America | Regional News

Continue Reading →

news

Gel formulation of a new male contraceptive on trial

The National Institutes of Health (NIH) is funding a clinical trial to see the safety and effectiveness of a new male contraceptive that would be available in gel for...

29 November 2018 news | North America | Regional News

Continue Reading →

news

QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Pharmaceutical and Biotechnology Sponsors

MIAMI, FL, November 27, 2018 – QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, today ...

29 November 2018 news | North America | Regional News

Continue Reading →